RxDoctor Payments Data

Shilpa Grover, MD

Gastroenterology · Boston, MANPI 1265464796

Payments from drug & device makers

What this record shows

That places this record below the midpoint for gastroenterology clinicians in MA, where the typical reported total is $854.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$387,933in research payments, 2019–2025

Across 2 payments — averaging $193,967 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$388K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$39,192
Medicare patients
145
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$31,553
LinzessLinaclotide16$15,557
Omeprazole37$693
Prednisone14$127
Pantoprazole Sodium12$58

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →